Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients

2008 ◽  
Vol 98 (1-3) ◽  
pp. 295-301 ◽  
Author(s):  
Anvita Kale ◽  
Sadhana Joshi ◽  
Nilesh Naphade ◽  
Swati Sapkale ◽  
M.S.V.K. Raju ◽  
...  
2000 ◽  
Vol 17 (1) ◽  
pp. 18-22 ◽  
Author(s):  
P. L. Riu ◽  
G. Riu ◽  
C. Testa ◽  
M. Mulas ◽  
M. A. Caria ◽  
...  

2008 ◽  
Vol 97 (6) ◽  
pp. 816-818
Author(s):  
Otávio A Moreno-Carvalho ◽  
Maria-Regina A Cardoso ◽  
Cristiana M Nascimento-Carvalho ◽  

2006 ◽  
Vol 42 (3) ◽  
pp. 287-292 ◽  
Author(s):  
Dennis R. Hoffman ◽  
Dianna K. H. Wheaton ◽  
Kathy J. James ◽  
Myla Tuazon ◽  
Deborah A. Diersen-Schade ◽  
...  

Endocrinology ◽  
2010 ◽  
Vol 151 (4) ◽  
pp. 1853-1862 ◽  
Author(s):  
Eriko Simamura ◽  
Hiroki Shimada ◽  
Nobuaki Higashi ◽  
Maimi Uchishiba ◽  
Hiroki Otani ◽  
...  

Leukemia inhibitory factor (LIF) promotes the proliferation of neuronal progenitor cells in the cerebrum. However, it remains unclear how fetal LIF level is regulated. Here we show evidence that maternal LIF signals drive fetal LIF levels via the placenta, thereby promoting neurogenesis in the fetal brain in rats. Chronological changes showed that LIF concentration in fetal sera (FS) and fetal cerebrospinal fluid peaked at gestational day (GD) 15.5, after the peak of maternal LIF at GD14.5. LIF injection into rat dams at GD15.5 increased the level of ACTH in FS and subsequently increased LIF levels in FS and fetal cerebrospinal fluid. The elevation of fetal LIF after LIF injection into dams was inhibited by in utero injection of anti-ACTH antibody into fetuses. Cultured syncytiotrophoblasts, which express the LIF receptor and glycoprotein 130, were induced to secrete ACTH and up-regulate Pomc expression by the addition of LIF. Nucleated red blood cells from fetuses at GD15.5, but not GD13.5 or GD17.5, displayed LIF secretion in response to ACTH. Moreover, injection of LIF into dams at GD13.5 or GD17.5 did not result in elevation of ACTH or LIF in fetuses. The labeling index of 5-bromo-2′-deoxyuridine-positive cells in the ventricular zone of the cerebral neocortex increased 24 h after injection of LIF into dams at GD15.5 but not GD13.5 or GD17.5. These results suggest that in rats maternal LIF induces ACTH from the placenta, which in turn induces fetal nucleated red blood cells to secrete LIF that finally increases neurogenesis in fetuses around GD15.


Vox Sanguinis ◽  
2012 ◽  
Vol 103 (3) ◽  
pp. 186-193 ◽  
Author(s):  
B. Culibrk ◽  
E. Stone ◽  
E. Levin ◽  
S. Weiss ◽  
K. Serrano ◽  
...  

2000 ◽  
Vol 17 (1) ◽  
pp. 18-22 ◽  
Author(s):  
P. L. De Riu ◽  
G. De Riu ◽  
C. Testa ◽  
M. Mulas ◽  
M. A. Caria ◽  
...  

2021 ◽  
pp. 222-224
Author(s):  
Jaclyn R. Duvall ◽  
Jerry W. Swanson

A 42-year-old healthy man sought care for transient episodes of neurologic deficits followed by severe headache. The first episode began with left hand weakness, numbness, and dysarthria, followed approximately 1 hour later by a right temporal headache. His symptoms spontaneously resolved after 8 hours. He had a second episode 2 days later manifested by confusion and bilateral lower extremity numbness, again followed by severe headache with symptoms resolving within 12 hours. A total of 8 episodes occurred over 3 weeks, each lasting 8 to 24 hours, with spontaneous resolution each time. His most recent episode occurred during cerebral angiography. Cerebrospinal fluid evaluation showed opening pressure, 190 mm H2O; white blood cells, 205/μ‎L, 97% lymphocytes; protein, 95 mg/dL; and glucose, 40 mg/dL. Electroencephalography demonstrated right greater than left generalized slowing, with increased-voltage rhythmic delta wave activity, in the frontal regions predominantly. Conventional cerebral angiography findings were normal, but the test appeared to provoke the patient’s previous episode. Neurologic examination was normal after his most recent episode resolved, and no further episodes were reported. This case highlights a typical presentation of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis. Because the disorder was self-limited, treatment was aimed at symptomatic management of headache. In this case patient with a secure diagnosis of headache and neurologic deficits with cerebrospinal fluid lymphocytosis and stereotypical episodes limited to 3 months after the initial presentation, additional testing was not indicated. Headache and neurologic deficits with cerebrospinal fluid lymphocytosis is a rare, self-limited, benign condition with migrainelike headache episodes accompanied by transient neurologic deficits usually lasting more than 4 hours, with some deficits lasting more than 24 hours.


2012 ◽  
Vol 7 (4) ◽  
pp. 325-328 ◽  
Author(s):  
Elizabeth M. Hines ◽  
Lise E. Nigrovic ◽  
Mark I. Neuman ◽  
Samir S. Shah

Sign in / Sign up

Export Citation Format

Share Document